Estradiol biosynthesis is a key biochemical trait of developing follicles. To study its regulation in equine follicles, the objectives of this study were to clone and determine the structure of equine cytochrome P450 aromatase (P450AROM), and characterize the regulation of P450AROM and P450 17␣-hydroxylase/C17-20 lyase (P45017␣) messenger RNAs (mRNAs) in vivo in equine preovulatory follicles isolated during hCGinduced ovulation. Two distinct P450AROM complementary DNAs (cDNAs) were isolated from an equine preovulatory follicle cDNA library. One clone was 2682 bp in length and included 115 bp of 5Ј-untranslated region (UTR), 1509 bp of open reading frame encoding a well conserved 503-amino acid protein, and 1058 bp of 3Ј-UTR. Its 5Ј-most region represented the equine homolog of exon 1f, previously designated brain specific. The other cDNA clone encoded a truncated protein and contained a distinct 5Ј-UTR characteristic of transcripts derived from promoter II, previously identified as the predominant ovarian mRNA. Northern blot analyses were performed using preovulatory follicles obtained during estrus between 0 -39 h after the administration of hCG and with corpora lutea isolated on day 8 of the estrous cycle (day 0 ϭ day of ovulation). The results showed a biphasic regulation of P450AROM mRNA expression: levels were highest in follicles at 0 h post-hCG, decreased significantly during the ovulatory process at 12 and 24 h (P Ͻ 0.05), and increased again between 30 -39 h post-hCG and in corpora lutea. When oligonucleotides specific for P450AROM mRNA variants were used as probes, a novel switching phenomenon was observed. Promoter II-derived transcripts accounted for the message present in follicles at 0 h post-hCG and in corpora lutea, whereas promoter 1f-derived mRNA was expressed exclusively during the ovulatory process (30 -39 h post-hCG). Levels of P45017␣ mRNA were high in follicles at 0 h, but significantly decreased after hCG treatment (P Ͻ 0.05), with lowest levels in follicles at 36 and 39 h post-hCG and in corpora lutea. Northern blots performed on isolated cellular preparations revealed that P450AROM and P45017␣ transcripts were localized exclusively in granulosa cells and theca interna, respectively. Equine aromatase promoters II and 1f were cloned from a genomic library, and putative transcription start sites were characterized by primer extension assays. Sequence analyses identified distinct potential regulatory elements in each promoter. Thus, this study identifies a novel aromatase promoter-switching phenomenon in equine granulosa cells during follicular luteinization and provides a new model in which aromatase promoter switching is induced in vivo. (Endocrinology 140: 4133-4141, 1999) 
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The tissue-specific distribution of several aromatase transcripts has been linked in part to the use of different promoters (7, 9, 10, 12, 13, 18 -21) . In humans, these promoters direct the synthesis of distinct aromatase messenger RNA (mRNA) variants that differ only by their 5Ј-noncoding termini. At least nine 5Ј-untranslated first exons, and thus mRNAs variants, have been identified, including exons I.1, I.2, I.3, I.4, I.5, I.6, PII, 2a, and 1f (22) . They are alternatively spliced into a common 5Ј-splice acceptor site found 38 bp upstream of the translation start site in exon 2 and generate transcripts that have distinct, but overlapping, tissue distribution (7) .
Increasing evidence suggests that switching of aromatase expression from one mRNA variant to another may be a key regulatory mechanism in several physiological and pathological processes. Distinct aromatase transcripts are expressed in early vs. midpregnancy in porcine placenta (12, 13, 23) as well as in fetal vs. adult human liver (24) . Several studies have shown that a similar switch occurs in healthy vs. cancerous human breast adipose tissue (24 -29) . It has been speculated that a switching mechanism may be involved in the ovulation/luteinization process (24) . However, results from the study of Jenkins et al. (30) did not support this concept, as only promoter II-derived aromatase transcripts were detected in human follicles and corpora lutea.
One key function of P450AROM is to produce large amounts of estradiol in mammalian preovulatory follicles (31) , and the obligatory role of estrogen synthesis in female reproduction was recently highlighted in mice by targeted disruption of the CYP19 gene (32) . In contrast to that in other species, the molecular control of follicular steroidogenesis in mares has remained largely uncharacterized. Yet, the equine preovulatory follicle offers a good model for the study of ovarian gene expression because it has a relatively large size (40 -50 mm in diameter), and its development can be precisely monitored in vivo by ultrasound imaging (33, 34) . Therefore, the objectives of this study were to clone and determine the primary structure of equine P450AROM, characterize the regulation of P450AROM and P450 17␣-hydroxylase/C17-20 lyase (P45017␣) mRNAs in a series of equine preovulatory follicles isolated during hCG-induced ovulation, and determine the cellular localization of each transcript.
Materials and Methods Materials
The equine genomic library and QuikHyb hybridization solution were purchased from Stratagene Cloning Systems (La Jolla, CA); the Prime-a-Gene labeling system and the DNA 5Ј-End Labeling System were obtained from Promega Corp. ( 
Cloning of equine cytochrome P450AROM and P45017␣ complementary DNAs (cDNAs)
The equine P450AROM and P45017␣ cDNAs were cloned from an expression library prepared from an equine preovulatory follicle isolated 36 h after the administration of an ovulatory dose of hCG (2500 IU), as previously described (35) . Approximately 100,000 phage plaques were screened, and hybridization was performed at 55 C with QuikHyb hybridization solution (Stratagene). The probes, including a 5Ј, 1.0-kb EcoRI restriction fragment of the rat P450AROM cDNA (36) and a 2.0-kb XhoI restriction fragment of the bovine P45017␣ cDNA (37) , were labeled with [␣-32 P]dCTP using the Prime-a-Gene labeling system (Promega Corp.) to a final specific activity greater than 1 ϫ 10 8 cpm/g DNA. Positive clones were plaque purified through secondary and tertiary screening, and pBluescript phagemids containing the cloned DNA insert were excised in vivo with the Ex-Assist/SOLR system (Stratagene). DNA sequencing was performed by the Sanger dideoxy nucleotide chain termination method (38) 
Isolation of equine preovulatory follicles and Northern blot analysis
Ovarian follicular development in Standardbred and Thoroughbred mares was monitored daily by ultrasonography (33) . When the preovulatory follicle reached 35 mm in diameter during estrus, ovulation was induced with hCG (2500 IU, iv). The ovary bearing the presumptive preovulatory follicle was removed via colpotomy 0, 12, 24, 30, 33, 36 , and 39 h post-hCG with a chain ecraseur (n ϭ 4 -5 follicles/time point) (35) . Also, three corpora lutea were isolated on day 8 of the estrous cycle using the same approach. The recovered ovary was kept in ice-cold Eagles's MEM supplemented with penicillin (50 U/ml)-streptomycin (50 g/ml; Life Technologies, Inc.), l-glutamine (2.0 mm; Life Technologies, Inc.), and nonessential amino acids (0.1 mm; Life Technologies, Inc.). Preovulatory follicles were dissected into preparations of follicle wall (theca interna with attached granulosa cells) and isolated theca interna and granulosa cells, as described (35) . All samples were stored at Ϫ70 C until RNA extraction. Animal procedures were approved by the institutional animal use and care committee.
RNA was extracted from equine tissues using TRIzol (Life Technologies, Inc.) and a Kinematica PT 1200C Polytron Homogenizer (Fisher Scientific, Fairlawn, NJ). For Northern analysis, RNA samples (10 g) were denatured at 55 C for 15 min in denaturing buffer, electrophoresed on a 1.2% agarose, and transferred by capillarity to a nylon membrane, as previously described (35) . A ladder of RNA standards was run with each gel, and ethidium bromide (10 g) was added to each sample before electrophoresis to compare RNA loading and determine the migration of standards. Hybridization was performed using the QuikHyb solution (Stratagene) and the following cDNA probes: a 0.5-kb EcoRI fragment of the equine P450AROM cDNA (clone A17), a 2.0-kb EcoRI/HindIII fragment of the equine P45017␣ cDNA, and the rat elongation factor Tu cDNA (EFTu) as a control gene for RNA loading and transfer (39) . Each cDNA was labeled using the Primea-Gene labeling system as described above, and stripping of hybridization signal was achieved by soaking filters in 0.1% SSC (standard saline citrate)-0.1% SDS for 30 min at 100 C.
To study the specific regulation of promoter II-and promoter 1f-derived aromatase transcripts in granulosa cells, two oligonucleotides complementary to unique sequences located at the 5Ј-end of each transcript were labeled using the DNA 5Ј-End Labeling System (Promega Corp.), and used as probes in Northern blot analysis. They included a 24-mer antisense oligonucleotide 5Ј-GTCTGCTGGTCAC TTCTAGTT-TCC-3Ј complementary to nucleotides 50 and 73 in promoter 1f-derived transcript (clone A17; Fig. 1 ), and a 23-mer oligonucleotide 5Ј-CCAAAAGGTACAT CTAGGACTCC-3Ј complementary to nucleotides 5 and 27 in promoter II-derived P450AROM transcript (clone A1; Fig. 1 ).
Cloning of equine aromatase promoter II and promoter 1f
DNA sequences located immediately upstream of aromatase exon II and exon 1f were cloned using an equine genomic library (Stratagene), following the manufacturer's protocol. To clone the equine aromatase promoter II, approximately 1 ϫ 10 6 genomic phage plaques were screened using a random primed, 0.5-kb EcoRI cDNA fragment corresponding to the 5Ј-end of the equine aromatase promoter II-derived cDNA (clone A1, Fig. 1 ). To clone the aromatase promoter 1f, the same genomic phage plaques were screened with a radioactive DNA fragment generated by PCR and corresponding to the first 77 bases of the equine aromatase promoter 1f-derived cDNA (clone A17; Fig. 1 ). The latter probe was generated by inclusion of 0.5 mCi [␣-
32 P]dATP (6000 Ci/ mmol) in a standard PCR reaction mixture (40) and by using clone A17 as template DNA, sense primer 5Ј-TTCCTAACAGCCGTGCATCAT-TAG-3Ј, and antisense primer 5Ј-CTGAGTCTGCTGGTCACTTCTAGT-3Ј. The DNA fragment was purified by electrophoresis on a 2% agarose gel. Six exon II-and three exon 1f-containing clones were isolated from the initial round and were purified through secondary and tertiary screening. After digestion with SacI, Southern blot analyses were performed using oligonucleotide probes corresponding to the 5Ј-end of each equine aromatase transcript (same oligonucleotides described for Northern blots). Fragments yielding a positive signal were subcloned into the pBluescript plasmid vector (Stratagene) and sequenced using a T7 Sequencing Kit (Pharmacia Biotech) and custom oligonucleotide primers (Life Technologies, Inc.).
Primer extension analysis
Primer extension analyses were performed in aqueous buffer, as previously described (35) . To determine the putative transcription start site of the promoter II-derived transcript, the primer extension assay used RNA extracted from a corpus luteum (50 g; day 8 of cycle), a tissue known to contain high levels of transcripts, and a 30-mer antisense oligonucleotide 5Ј-GGCGAAGCAATGTAAAGGCCTGTGGAA ATC-3Ј corresponding to the region located between ϩ51 and ϩ80 bp from the beginning of clone A1 (Fig. 1b) . RNA isolated from spleen served as a negative control. The putative transcription start site of the promoter 1f-derived aromatase transcript was determined using RNA extracted from granulosa cells of a preovulatory follicles isolated 30 h post-hCG (30 g) and a 30-mer antisense oligonucleotide (5Ј-GGCCTGAGTCTGCTGGTCACTTCTAGTTTC-3Ј) corresponding to the region located between ϩ51 and ϩ80 bp from the beginning of clone A17 (Fig. 1b) . RNA isolated from spleen and corpus luteum served as the negative control. The extension products were analyzed by electrophoresis on a 6% polyacrylamide-7 m urea gel, and the putative sites of transcription initiation were determined by comparisons with adjacent sequencing reactions that used the same oligonucleotides as primers and two corresponding aromatase genomic clones that contained these regions as templates.
Statistical analysis
Relative levels of P450AROM and P45017␣ mRNAs were quantified by densitometric analysis of autoradiogram bands using a computerassisted image analysis system (Collage Macintosh program, Fotodyne, Inc., New Berlin, WI). The EFTu signal was also quantified and used to normalize results. Data were expressed as ratios of P450AROM to EFTu and P45017␣ to EFTu (n ϭ 4 follicles/time point). One-way ANOVA was used to test the effect of time after hCG on relative levels of P450AROM and P45017␣ mRNAs. When ANOVAs indicated significant differences (P Ͻ 0.05), Dunnett's test was used for multiple comparisons with the control (0 h post-hCG). Statistical analyses were performed using JMP software (SAS Institute, Inc., Cary, NC).
Results

Characterization of equine cytochromes P450AROM and P45017␣ cDNAs
Eighteen positive clones were originally purified after screening the equine expression library with the rat aromatase cDNA. Five of them, designated A1, A6, A12, A13, and A17, were selected for DNA sequencing, as others appeared to represent shorter fragments of the same cDNAs. Sequence analysis revealed that the clones corresponded to distinct aromatase transcripts, represented by clone A17 (similar to A12 and A6) and clone A1 (similar to A13; Fig. 1 ). Clone A17 was 2682 bp in length and included a 5Ј-untranslated region (UTR) of 115 bp, an open reading frame of 1509 bp, and a 3Ј-UTR of 1058 bp. The open reading frame encoded a 503-amino acid protein that included all conserved features characteristic of cytochrome P450AROM, such as a membrane-spanning region, an I helix, a heme-binding region, as well as a domain encompassing a putative cAMPdependent protein kinase phosphorylation site (Fig. 1) . The 5Ј-end of clone A17 (bases 1-77; Fig. 1B ) was found to be the equine homolog of aromatase exon 1f, often designated as brain specific (21, (41) (42) (43) . Clone A17 was designated as a promoter 1f-derived aromatase transcript. In contrast, the 5Ј-end of clone A1 (bases 1-61; Fig. 1B) represented the region immediately upstream of exon II. This latter region has previously been cloned by RT-PCR from equine tissues (9) , and is known to be the primary mRNA species present in granulosa cells of several species (9, 18, 30, 36) . Clone A1 was designated a promoter II-derived transcript. However, clone A1 was short and encoded a truncated 347-amino acid protein lacking important 3Ј-structural elements such as the heme-binding domain (data not shown). Database homology searches showed that homologous sequences ceased after the splice junction between exons 8 and 9, suggesting that the clone may be a splice variant or an artifact of the cloning process.
Twelve P45017␣ clones were isolated from the equine cDNA library using a bovine homologous probe. Partial DNA sequencing of one selected clone showed that it was identical to an equine testicular P45017␣ cDNA previously characterized (data not shown) (44) .
Regulation of equine P450AROM and P45017␣ mRNAs in preovulatory follicles
Changes in levels of aromatase mRNA during the ovulation-luteinization process were studied by Northern blots using a cDNA probe common to both transcripts. Results showed a biphasic pattern of aromatase expression after gonadotropin treatment (Fig. 2) . High levels of aromatase mRNA were detected in walls of follicles isolated before hCG (0 h; Fig. 2A ), but a marked drop in transcripts was observed 12 and 24 h post-hCG (P Ͻ 0.05). Then, aromatase levels increased again between 30 and 39 h post-hCG and were elevated in mature equine corpora lutea ( Fig. 2A) . To assess the cellular localization of the aromatase message within the follicle wall, Northern blots were performed on isolated preparations of granulosa cells and theca interna. Results showed that expression of aromatase transcripts was restricted to the granulosa cell layer and followed a pattern similar to that observed in follicle wall (Fig. 3) . The size of the P450AROM mRNA was approximately 3.0 kb in most samples, with the exception of those isolated before hCG treatment (0 h post-hCG), where transcripts of about 4.0 and 1.2 kb were also observed. No aromatase transcripts were detected in theca interna (Fig. 3) .
The concomitant regulation of P45017␣ mRNA in equine preovulatory follicles and corpora lutea was studied by Northern blots using the same membranes. Levels of P45017␣ mRNA were high in follicles at 0 h, but significantly decreased after hCG treatment (P Ͻ 0.05), with lowest levels in follicles at 36 and 39 h post-hCG and in corpora lutea (Fig.  2B ). When Northern blots were performed with isolated cellular preparations, no P45017␣ mRNAs were detected in granulosa cells, except for a relatively weak signal in a few samples, probably resulting from contamination by theca interna cells (Fig. 3) . In contrast, P45017␣ expression was high in theca interna of follicles isolated between 0 -33 h post-hCG, but dropped markedly thereafter (P Ͻ 0.05; Fig. 3 ).
Differential expression of promoter II-and 1f-derived aromatase transcripts
The potential regulation of two distinct aromatase mRNAs in granulosa cells was studied using mRNA-specific, endlabeled oligonucleotide probes representing either promoter II-or promoter 1f-derived transcripts. The results suggested the presence of successive aromatase promoter-switching events during follicular luteinization and corpus luteum formation. Levels of promoter II-derived transcripts were high before hCG treatment (0 h), dropped drastically after hCG treatment, and remained very low before ovulation (Fig. 4A) . Conversely, promoter 1f-derived mRNAs were undetectable at 0 h, but were induced between 30 -39 h post-hCG (Fig. 4B) . Interestingly, the process reversed itself after ovulation, as promoter 1f-derived mRNA disappeared and promoter IIderived transcripts reappeared in the corpus luteum (Fig. 4) . The summation of promoter II-and promoter 1f-derived aromatase mRNAs seemed to represent the overall aromatase expression detected using a nonspecific probe (Fig. 3) .
Cloning of aromatase promoters II and 1f, and characterization of putative transcription initiation sites
To determine the complete structure of the 5Ј-UTR of each aromatase transcript and identify potential regulatory elements involved in their expression, the 5Ј-flanking regions of exon II and exon 1f were cloned from an equine genomic library. Approximately 1.1 kb of each putative promoter was sequenced, and potential cis-acting elements were identified from a transcription factor database (Figs. 5 and 6 ). The equine aromatase promoter II contains a highly conserved adrenal 4 binding protein/steroidogenic factor-1 (SF-1) element involved in cAMP-dependent and -independent regulation in granulosa cells of other species (45-47) (Figs. 5 and   FIG. 2 . Regulation of P450AROM and P45017␣ mRNA in equine preovulatory follicles. Preparations of follicle wall were obtained from preovulatory follicles isolated between 0 -39 h after hCG, and two corpora lutea (CL) were isolated on day 8 of the estrous cycle. Samples of total RNA (10 g/lane; two follicles per time point) were analyzed by Northern blotting using an equine P450AROM (A), an equine P45017␣ cDNA (B), and the rat elongation factor Tu (EFTu) as a control gene for RNA loading (C). Brackets on the left show the migration of 28S and 18S ribosomal bands, and markers on the right indicate the migration of RNA standards. Filters in A, B, and C were exposed to film at Ϫ70 C for 1.5, 4, and 2 h, respectively. 7A). However, a cAMP response element (CRE)-like region known to bind cAMP-binding protein (CREB) in rat and human (45, 48) , but not in bovine (49) , ovarian tissues is not conserved in the horse (Fig. 7B) . Alignment of the first 250 bases of the equine promoter 1f with the corresponding human and mouse regions shows a remarkable level of homology among species (90% and 96% identity between equine and murine, and equine and human sequences, respectively). This region features several perfectly conserved elements, notably overlapping c-myc and GRE consensus sites. Although genomic clones ranged in size from about 12-25 kb, no single clone was found to include both promoters, indicating that these equine aromatase promoters are separated by at least several thousand bases as reported in humans (7) .
Primer extension analysis of promoter II-derived mRNA revealed a single putative transcription start site corresponding to a cytosine residue located 30 bp downstream of a consensus TATA box (Figs. 5 and 8 ). This cytosine residue was positioned 16 bp upstream of the first base of the aromatase cDNA clone A1 (Fig. 1) , indicating that the total length of the 5Ј-UTR of promoter II-derived transcripts is 115 bp. Primer extension analysis of promoter 1f-derived transcripts identified a major putative transcription initiation site at a cytosine residue located 31 bp downstream of a consensus TATA box (Figs. 6 and 8) . The criteria used to select this band as a major site was the presence of a strong signal with the granulosa cell RNA extract (which contains promoter 1f-derived mRNA) and the absence of a signal with the corpus luteum extract (which does not contain promoter 1f-derived mRNA; Fig. 4 ). The cytosine residue was located 16 bp upstream of the first base of the aromatase cDNA clone A17, giving an overall length of 93 bp for exon 1f and a total length of 131 bp for the 5Ј-UTR of promoter 1f-derived transcripts. Longer, but less abundant, extension products were observed with promoter 1f-derived transcripts (data not shown). These products were apparently transcribed down- FIG. 3 . Regulation of P450AROM and P45017␣ mRNA in granulosa cells and theca interna of equine preovulatory follicles. Isolated preparations of granulosa cells (A) and theca interna (B) were obtained from equine preovulatory follicles isolated between 0 -39 h after hCG. Samples of total RNA (10 g/lane; n ϭ 2 follicles/time) were analyzed by Northern blotting using an equine P450AROM (a), an equine P45017␣ cDNA (b), and the rat elongation factor Tu (EFTu) as a control gene for RNA loading (c). In addition, preparations of theca interna (TI; 0 h) and of a corpus luteum (CL; day 8 of cycle) were included in A, whereas samples of granulosa cells (GC; 39 h) and of a corpus luteum (CL; day 8 of cycle) were included in B. Brackets on the left show the migration of 28S and 18S ribosomal bands, and markers on the right indicate the migration of RNA standards. Granulosa cell filters in a, b, and c were exposed to film at Ϫ70 C for 1, 4, and 2 h, respectively, whereas theca interna filters in a, b, and c were exposed for 1.5, 4, and 2 h, respectively.
stream from two additional TATAA elements found in the promoter 1f at positions Ϫ87/Ϫ92 and Ϫ111/Ϫ116 (ϩ1 ϭ major putative transcription initiation site). These TATA boxes are also conserved in the mouse and human promoter 1f (21, 41) , but their relative functional significance has not been determined.
Discussion
This study is the first to report an aromatase promoterswitching phenomenon in granulosa cells during follicular luteinization and provides a novel model in which aromatase promoter switching is induced in vivo. To date, promoter switching had been reported in distantly separated developmental (12, 23) or pathological (24 -27, 50) stages in vivo, and in human mononuclear leukemic THP-1 cells and peripheral blood lymphocytes in vitro (51, 52) . In the present study, a fine time-course dissection of the regulation of cytochrome P450AROM was realized in preovulatory follicles of mares, a species with a relatively long ovulatory process (36 -48 h from hCG to ovulation) (53, 54) . The cloning of two distinct equine follicular aromatase transcripts and studies on their expression after hCG-induced luteinization/ovulation revealed a dual regulation of promoter II-and promoter 1f-derived transcripts in granulosa cells. The down-regulation of promoter II-derived mRNAs with the accompanying induction of promoter 1f-derived mRNAs in granulosa cells after hCG treatment imply a first switching phenomenon, whereas the presence of promoter II-derived transcripts and the disappearance of promoter 1f-derived transcripts in corpora lutea suggest a second switching event. The use of alternate aromatase promoters was thought not to occur during the ovulatory process, as promoter II-derived mRNA was found to predominate in human follicles and corpus luteum (30) . However, this latter study does not contradict our results, as it did not analyze samples from the time window in which switching occurred in equine granulosa cells. Further studies will be needed to determine whether aromatase promoter switching during follicular luteinization also occurs in humans or other animal species.
The elevated expression of promoter II-derived aromatase transcripts in equine follicles before hCG treatment is in keeping with previous reports showing that it is the predominant mRNA species in granulosa cells (18, 30, 36, 49) . Also, the selective localization of aromatase mRNA in granulosa cells agrees with the immunohistochemical localization of the protein in equine follicles (55, 56) , and the steroidogenic capacities of isolated equine follicular cells in vitro (57) , thus resolving a previous controversy on the site of estrogen biosynthesis in the equine follicle (34) . This study reports the cloning and characterization of the equine aromatase promoter II. Some of the molecular mechanisms involved in the regulation of this promoter have been studied in other species, and at least two cis-elements appear crucial for cAMP- dependent and -independent expression in human and rat granulosa cells (45) (46) (47) (48) . A first element, a consensus SF-1-binding site conserved in all species, appears to mediate both constitutive and inducible aromatase transcription (45) (46) (47) . A second element, a CRE-like element to which CREB can bind, appears required to achieve optimal transcriptional activity in rats and humans (44, 47) . However, this latter element is poorly conserved in other species and contains a 1-bp deletion in the equine (this study), bovine (49) , and porcine (16) promoters. In cattle, this deletion was initially thought to be responsible for the lack of aromatase expression in bovine luteal cells. However, a site-directed mutagenesis study designed to render the bovine CRE-like site identical to its human counterpart resulted only in partial restoration of cAMP-inducible promoter activity in luteal cells, suggesting that other elements are involved (49) . The marked drop in promoter II-derived aromatase transcripts in equine follicles after hCG treatment agrees with a similar down-regulation in other species after the LH surge in vivo (36, 58 -61) . In rat granulosa cells, the decrease in promoter II activity and aromatase mRNA was associated with a drop in SF-1 and in the A kinase regulatory subunit type II (RII␤), but not in CREB expression or binding activity (47, 60, 62) .
The observed induction of promoter 1f-derived aromatase transcripts in equine granulosa cells is novel. Exon 1f-containing mRNA was originally cloned from brain tissues and has been described as brain specific (21, (41) (42) (43) . However, several aromatase expression studies have shown a vast tissue distribution for many aromatase mRNA species (7, 10, 24) , suggesting that the tissue specificity model for aromatase promoter usage may be oversimplified. This view is also supported by recent reports, including this one, that show the use of alternative aromatase promoters in a given tissue (10, 12, 20, (23) (24) (25) (26) (27) . The molecular mechanisms involved in promoter 1f-derived aromatase expression have not been characterized, which contrasts with studies on promoter II. Although promoter 1f has previously been cloned in humans (41) and mice (21) , no regulatory elements have been functionally identified. Potential cis-acting elements include the highly conserved, overlapping c-myc and glucocorticoid response element identified in horses (this study), humans (41) , and mice (21) . Recent studies have shown an increase in c-myc expression in rat granulosa cells during hCG-induced luteinization (62, 63) . Also, a glucocorticoid response cis-element present in the human aromatase promoter I.4 is required (in conjunction with glucocorticoids) for cytokine-induced transcription in adipocytes via the Janus kinase/STAT (signal transducer and activator of transcription) pathway (64) . Whether these pathways are involved in promoter 1f-derived aromatase expression in equine granulosa cells remains to be determined.
This study provides a first characterization of the regulation and cellular localization of cytochrome P45017␣ transcripts in equine preovulatory follicles. Selective expression of P45017␣ mRNA in the theca interna layer is similar to reports in other species (58, 59, 61, 65) and supports studies in vitro showing that secretion of androgens was observed in cultures of equine theca interna cells, but not in those of granulosa cells (57) . No major changes were observed in levels of P45017␣ mRNA in theca interna between 0 and 33 h post-hCG, but a marked drop occurred thereafter. Comparable loss of P45017␣ mRNA has been observed in bovine (58) , porcine (61) , and rat (66) theca interna after the LH surge. Interestingly, the time course of P45017␣ mRNA disappearance (between 33-36 h post-hCG) was distinct from that of promoter II-derived aromatase transcripts in granu- losa cells (between 0 -12 h post-hCG), suggesting the presence of separate down-regulatory mechanisms in each follicular cell type. However, the decrease in P45017␣ transcript in theca interna coincides precisely with the loss of steroidogenic acute regulatory protein mRNA in theca interna (67) . This apparent reduction in thecal steroidogenic capacity could relate to the reported demise of the layer at the time of ovulation in mares (34, 68) . Despite high levels of aromatase transcripts in the equine corpus luteum, estrogen biosynthesis is very limited during the luteal phase (34) . Insufficient luteal P45017␣ expression, and thus aromatizable androgen substrates, has been proposed to be rate-limiting in luteal estrogen synthesis (69) .
In summary, this study reports the cloning and characterization of two equine aromatase transcripts, as well as approximately 1 kb of genomic sequences putatively involved in their transcription. This study provides a first characterization of the regulation and cellular localization of the P450AROM and P45017␣ mRNAs during the ovulatory process, with results indicating that the classic two-cell (theca interna/granulosa cells), two-gonadotropin (LH/FSH) model for estradiol production is operative in the mare. Most importantly, we report the presence of a novel aromatase promoter-switching phenomenon in equine granulosa cells during follicular luteinization, characterized by a down-regulation of promoter II-and an up-regulation of promoter 1f-derived transcripts after hCG treatment. This phenomenon apparently reverses itself after ovulation, as promoter II-derived mRNAs become elevated, whereas those derived from promoter If disappear in the corpus luteum. Considering the potential role of aromatase promoter switching in various physiological and pathological processes and the uncharacterized nature of its molecular control, we propose that the equine preovulatory follicle provides a valuable model system to study this phenomenon.
FIG. 8.
Putative transcription initiation sites of promoter II-and promoter 1f-derived aromatase transcripts. Primer extension analyses were performed using antisense oligonucleotides complementary to 5Ј-UTR regions of promoter II-and promoter 1f-derived transcripts (A and B, respectively). Primers were hybridized to RNA samples containing promoter II-derived transcripts (corpus luteum; A) and promoter 1f-derived mRNA (granulosa cells 30 h post-hCG; B), and extension reactions were analyzed on a 6% polyacrylamide gel, as described in Materials and Methods. Results revealed 96-nucleotide extension products corresponding to the putative transcription initiation sites of promoter II-and promoter 1f-derived aromatase mRNA.
